Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)

NCT06696131 is registered in ClinicalTrials.gov with Gaurav Gupta, MD as lead sponsor.

NCT NCT06696131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06696131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
Lead sponsor
Gaurav Gupta, MD
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 15, 2026
Completion date
December 31, 2028
Enrollment
5 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic strokes, intracerebral hemorrhage, intracranial hemorrhages